Xenetic Biosciences Inc (XBIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.45
• Market Cap: $5.59M
• EPS: $-2.04
• 52-Week High: $13.93
• 52-Week Low: $1.90

Market Sentiment

Xenetic Biosciences Inc currently has a Neutral sentiment score of -0.11.

About Xenetic Biosciences Inc

Xenetic Biosciences Inc. is a forward-thinking biopharmaceutical company located in Framingham, Massachusetts, specializing in the development of next-generation cancer therapies. Through its proprietary XCART platform, the company is pioneering customized chimeric antigen receptor T (CAR T) cell treatments that specifically target and destroy tumor neoantigens unique to individual patients. Committed to addressing critical unmet medical needs in oncology, Xenetic is poised to significantly e...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Xenetic Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does XBIO pay dividends?

Xenetic Biosciences Inc (XBIO) does not currently pay a regular dividend.

What is XBIO's market cap?

Xenetic Biosciences Inc (XBIO) has a market capitalization of $5.59M with a current stock price of $2.45.